Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV: A Randomized Controlled Trial.

NCT05135039 is registered in ClinicalTrials.gov with xiaolong zhao as lead sponsor.

NCT NCT05135039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV: A Randomized Controlled Trial.
Lead sponsor
xiaolong zhao
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
218 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, prediabetes